ANTI-TRYPTIC PROPERTY OF CANCER-RELATED GLYCOPROTEIN EDC1
- 1 January 1978
- journal article
- research article
- Vol. 38 (2) , 452-457
Abstract
A cancer-related urinary glycoprotein EDC1 from an acute myelocytic leukemia inhibits the action of trypsin and chymotrypsin on casein and synthetic substrates. The amino acid and carbohydrate compositions of EDC1 are different from those reported for pregnancy-related urinary trypsin inhibitors.This publication has 13 references indexed in Scilit:
- Urinary Excretion of the Cancer-Related Glycoprotein EDCI: Effect of ChemotherapyAnnals of Internal Medicine, 1977
- [20] The porcine pepsins and pepsinogensPublished by Elsevier ,1970
- PORCINE PANCREATIC CARBOXYPEPTIDASE A SYSTEM .1. 3 FORMS OF ACTIVE ENZYME1963
- A MODIFIED SPECTROPHOTOMETRIC DETERMINATION OF CHYMOTRYPSIN, TRYPSIN, AND THROMBINCanadian Journal of Biochemistry and Physiology, 1959
- The Thiobarbituric Acid Assay of Sialic AcidsJournal of Biological Chemistry, 1959
- Partial Purification of the Trypsin Inhibitor in UrineScandinavian Journal of Clinical and Laboratory Investigation, 1959
- Direct spectrophotometric measurement of the peptide bond: Application to the determination of acylase IBiochimica et Biophysica Acta, 1958
- A PROTEOLYTIC INHIBITOR WITH ANTICOAGULANT ACTIVITY SEPARATED FROM HUMAN URINE AND PLASMAJournal of Biological Chemistry, 1955
- ACTIVITY OF CATHEPTIC ENZYMES IN PARA-DIMETHYLAMINOAZOBENZENE HEPATOMAS1947
- THE ESTIMATION OF PEPSIN, TRYPSIN, PAPAIN, AND CATHEPSIN WITH HEMOGLOBINThe Journal of general physiology, 1938